IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CYDY

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2021Q2 2021Q1 2021
Cash & Equivalents15.664.9815.66--16.4021.3424.92--1.400.152.035.112.404.681.368.886.53
Accounts Receivable------------------------------0.230.04
Inventory----------------------------82.6788.5691.56
Total Current Assets18.448.8418.44--20.9824.6327.74--9.918.8411.9714.116.559.8692.35101.81102.79
Property, Plant & Equipment----------------------------0.120.120.13
Intangible Assets----------------------------1.041.151.39
Total Non-current Assets*0.060.100.06--0.210.240.28--0.360.400.440.530.5218.541.731.892.18
Total Assets18.508.9418.50--21.1924.8828.02--10.279.2412.4114.647.0728.3994.08103.70104.97
Accounts Payable13.4814.2513.48--15.1314.2414.16--62.0862.3362.7762.6767.1968.9962.3958.0165.94
Total Current Liabilities50.4385.1150.43--70.5770.6369.56--129.48123.41129.05121.33122.69122.32116.09115.91129.64
Long-term Debt40.5342.1740.53--45.8446.0845.31--44.2545.8544.8745.4345.2143.9540.50----
Total Non-current Liabilities*72.3643.5772.36--43.6143.6443.68--0.180.210.250.320.350.390.450.490.52
Total Liabilities122.78128.68122.78--114.17114.27113.23--129.65123.62129.30121.65123.04122.71116.54116.40130.16
Retained Earnings(920.62)(915.93)(920.62)--(881.83)(877.07)(872.30)--(874.74)(862.82)(853.26)(823.05)(809.35)(782.86)--(603.35)(542.65)
Total Stockholder Equity(104.29)(119.75)(104.29)(119.75)(99.50)(89.39)(92.98)(89.39)(85.21)(114.38)(116.89)(107.01)(115.97)(94.31)(22.46)(12.70)(25.19)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q4 2021Q3 2021Q2 2021
Total Revenue------------------------------0.04--0.000.000.23
Cost of Revenue------------------------------0.00----0.000.05
Gross Profit------------------------------0.04----0.000.17
Research & Development----------------3.600.651.081.910.980.940.140.58(4.91)14.379.139.04
Selling, General & Admin2.281.651.801.711.851.512.291.603.032.762.312.692.792.975.046.3310.348.9910.1416.20
Total Operating Expenses------------------------------21.68----19.4025.50
Operating Income(5.64)(6.30)(21.69)(4.94)(5.07)(4.00)(3.71)22.44(6.63)(3.41)(3.40)(4.61)(3.78)(3.92)(23.16)(9.71)(79.05)(23.64)(19.40)(25.32)
Pretax Income(9.86)(4.69)(22.61)(5.54)(5.96)(4.76)(4.77)19.23(16.79)(11.92)(9.56)(11.57)(18.64)(13.70)(26.49)(20.99)(110.95)--(32.33)(36.60)
Tax Provision0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Net Income(9.86)(4.69)(22.61)(4.69)(22.61)(5.54)(4.77)(4.76)(4.77)19.23(9.56)(11.57)(18.64)(13.70)(26.49)(20.99)(110.95)--(32.33)(36.60)
Basic EPS--0.00(0.02)0.00(0.02)0.000.000.02(0.02)(0.01)(0.01)(0.01)(0.02)(0.02)(0.03)(0.03)----(0.05)(0.05)
Diluted EPS--0.00(0.02)0.00(0.02)0.000.000.02(0.02)(0.01)(0.01)(0.01)(0.02)(0.02)(0.03)(0.03)----(0.05)(0.06)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow(4.93)(5.52)(4.35)(2.45)(5.66)(4.96)(3.59)5.44(1.65)(2.33)(2.50)(4.49)(3.41)(6.22)(4.41)(11.07)(32.81)(11.05)(28.89)(31.74)
Capital Expenditures------------------------------0.010.020.020.010.01
Free Cash Flow*------------------------------(11.08)(32.83)(11.06)(28.90)(31.75)
Investing Cash Flow------------------------------(0.01)(0.02)(0.02)-0.00(0.01)
Financing Cash Flow1.1316.190.00(0.12)1.170.020.009.673.443.630.654.021.3514.732.3311.5252.484.5531.234.35
← Scroll for more columns →

* Derived from reported values